Last night Scott Brown and Martha Coakley had a debate moderated by David Gergen. The link to the video of the entire debate is here. From the excerpts that I have seen, Scott Brown won this debate including the comment in response to David Gergen, “It’s not the Kennedy Seat. It’s The People Seat.” Martha Coakley is now on the attack with help from the DSCC, Bill Clinton, (you know it’s bad when they bring out the big dog), MoveOn, and Big Pharma. You can thank these special interest group representatives if Coakley wins and the abomination of health care reform gets passed.
But money is coming to the rescue of Democrat Martha Coakley — healthcare industry lobbyist money, specifically.
Tim Carney identifies several of her top fundraisers. Take a look at who they represent:
- Thomas Boggs, Patton Boggs: Bristol-Myers Squibb
- Chuck Brain, Capitol Hill Strategies: Amgen, BIO, Merck, PhRMA
- Susan Brophy, Glover Park Group: Blue Cross, Pfizer
- Steven Champlin, Duberstein Group: AHIP, Novartis, Sanofi-Aventis
- Licy Do Canto, Raben Group: Amgen
- Gerald Cassidy, Cassidy & Associates: U. Mass Memorial Health Care
- David Castagnetti, Mehlman, Vogel, Castagnetti: Abbot Labs, AHIP, Astra-Zenaca, General Electric, Humana, Merck, PhRMA.
- Steven Elmendorf, Elmendorf Strategies: Medicines Company, PhRMA, United Health
- Shannon Finley, Capitol Counsel: Amgen, Astra-Zeneca, Blue Cross, GE, PhRMA, Sanofi-Aventis.
- Heather Podesta, Heather Podesta & Partners: Cigna, Eli Lilly, HealthSouth
- Tony Podesta, Podesta Group: Amgen, GE, Merck, Novartis.
- Robert Raben, Raben Group: Amgen, GE.
Of course, this is how politics works. Lobbyists for various corporations and causes get involved wherever they can for candidates of both parties. But when you see all these big pharma (and insurance!) representatives coming with cash for a crucial vote, you know which side they’re on.
On the flipside, Scott Brown’s MoneyBomb pulled in $1,303,302.50; well over the $500K goal, from regular Americans.